Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06973785 · ClinicalTrials.gov registry record · Phase 3
Non-Narcotic Pain Control After ACL Reconstruction
A Phase 3 study of ACL Injuries and ACL - Anterior Cruciate Ligament Rupture, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 30
- Enrollment target
- 3
- Study locations
NCT06973785 is a Phase 3 study of ACL Injuries and ACL - Anterior Cruciate Ligament Rupture that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 30 participants. The trial reports 3 study locations across 2 states.
The verdict
NCT06973785, a Phase 3 study of ACL Injuries and ACL - Anterior Cruciate Ligament Rupture, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 30 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a double-blind randomized controlled trial of standard of care therapy, either oral ketorolac (experimental group) or oral oxycodone (control group) to demonstrate efficacy in reducing the percentage of narcotic doses taken and documenting the number of patients with no exposure to any narcotics (take zero oxycodone) after undergoing primary knee ACL reconstruction outpatient surgery.
Conditions Studied
Interventions
- DRUG dispense of study drug
- DRUG Ketorolac
Study Locations (3)
Ohio
- Cleveland clinic sports medicine - Garfield
- Cleveland Clinic - Strongsville
Florida
- Cleveland Clinic Coral Springs - Coral Springs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-07-15 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06973785
The ClinicalTrials.gov registry entry for NCT06973785 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with ACL Injuries appearing as the primary indexed condition, and to 2 interventions - of which dispense of study drug is the first listed.
NCT06973785 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Florida.
Frequently Asked Questions
What is clinical trial NCT06973785 about?
NCT06973785 is a clinical study titled "Non-Narcotic Pain Control After ACL Reconstruction". This is a double-blind randomized controlled trial of standard of care therapy, either oral ketorolac (experimental group) or oral oxycodone (control group) to demonstrate efficacy in reducing the percentage of narcotic doses taken and documenting the number of patients with no exposure to any narco...
What is the current status of trial NCT06973785?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2025-07-15. Estimated completion is 2026-12-31.
What conditions does trial NCT06973785 study?
This clinical trial studies the following conditions: ACL Injuries, ACL - Anterior Cruciate Ligament Rupture.
What interventions are being tested in trial NCT06973785?
The interventions under investigation include: dispense of study drug (DRUG), Ketorolac (DRUG).
Who is sponsoring clinical trial NCT06973785?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06973785 being conducted?
This trial has 3 study locations across Florida, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ACL Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.